ResearchIn-Press PreviewImmunologyInfectious diseaseInflammation
Open Access |
10.1172/jci.insight.199201
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by
Varghese, J.
in:
PubMed
|
Google Scholar
|
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Huang, L. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Carro, S. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Landy, E. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Frank-Kamenetskii, A. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Klinghoffer, H. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Morrissette, J. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Dang, V. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by Eisenlohr, L. in: PubMed | Google Scholar
1Rheumatology and Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, United States of America
2Rheumatology and Immune Dysregulation, Children’s Hospital of Philadelphia, Philadelphia, United States of America
3Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, United States of America
4Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America
Find articles by
Canna, S.
in:
PubMed
|
Google Scholar
|
Published October 20, 2026 - More info
Hemophagocytic Lymphohistiocytosis (HLH) is a hyperinflammatory syndrome with multiple contributors, often including an infectious trigger. The Macrophage Activation Syndrome (MAS) subtype is linked to marked IL-18 excess, cytotoxic T-lymphocyte (CTL) activation, and natural killer (NK) cell abnormalities. We asked how excess IL-18 shapes NK and CTL responses to viral challenge. Mice with chronic IL-18 overproduction (Il18tg), showed baseline NK-cytopenia and CTL activation resembling MAS-susceptible patients. NK transcriptomes reflected IL-18/IFNg-axis activation and cell cycle upregulation. LCMV infection of Il18tg mice causes HLH/MAS without affecting viral control, but is not a significant NK challenge. Early after infection with NK-dependent mousepox, Il18tg NKs failed to activate appropriately, but CTLs quickly hyperactivated and mousepox control remained intact. Mousepox-infected Il18tg mice then developed signs of HLH/MAS including hepatosplenic necrosis. Their viral control was impaired, possibly because they failed to expand mousepox-specific CTLs. Il18bpKO mice, despite more normal resting lymphocytes, succumbed similarly to viremic HLH/MAS. Transfer of pre-activated NKs into Il18tg mice partially rescued virus-specific CTL responses, viral control, and survival. Thus, excess IL-18 contributes to HLH/MAS via disparate effects on CTL and NK cells, demonstrating a novel, context-specific NK immunodeficiency and highlighting how subtle host-pathogen interactions can affect the mechanisms and treatment rationale of life-threatening HLH/MAS.